# Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation

> **NCT02889562** · PHASE2,PHASE3 · COMPLETED · sponsor: **Sanford Health** · enrollment: 56 (actual)

## Conditions studied

- Coronary Artery Bypass Grafting
- Postoperative Atrial Fibrilation
- Stroke
- Systemic Embolism
- Deep Venous Thrombosis

## Interventions

- **DRUG:** Apixaban
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT02889562
- **Lead sponsor:** Sanford Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2019-05-11
- **Final completion:** 2019-05-11
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2021-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02889562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02889562, "Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02889562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*